Colchicine myotoxicity: Case reports and literature review

Pharmacotherapy

Volumn 24, Issue 12 I, 2004, Pages 1784-1792

  Wilbur, Kerry ^a   Makowsky, Mark ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adverse effect; Colchicine; Myopathy; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALLOPURINOL; AMLODIPINE; ASPARTATE AMINOTRANSFERASE; BUMETANIDE; CODEINE; COLCHICINE; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN A; DOCUSATE SODIUM; ERYTHROMYCIN; ERYTHROPOIETIN; GABAPENTIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; METOCLOPRAMIDE; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; REPAGLINIDE; SIMVASTATIN; STREPTOKINASE; TOLBUTAMIDE; UNINDEXED DRUG; VINCRISTINE; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; AGED; AMYLOIDOSIS; ANEMIA; ANOREXIA; AREFLEXIA; CASE REPORT; CHRONIC KIDNEY FAILURE; COGNITIVE DEFECT; COMORBIDITY; DEMYELINATION; DIALYSIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GOUT; HEART TRANSPLANTATION; HEPATITIS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER DISEASE; LONG TERM EXPOSURE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOTONIA; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PARESTHESIA; PEMPHIGOID; RASH; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SHOULDER PAIN; STROKE; SYMPTOM; VOMITING;

AGED; AGED, 80 AND OVER; COLCHICINE; FEMALE; HUMANS; MIDDLE AGED; MUSCULAR DISEASES;

EID: 9744279740     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.17.1784.52334     Document Type: Review

References (73)

1. Lascaratos J. Arthritis in Byzantium (AD 324-1453): unknown information from non-medicinal literature sources. Ann Rheum Dis 1995;54:951-7.
2. Douglas WW, Ryu JH, Bjoraker JA, et al. Colchicine versus prednisone as treatment of usual interstitial pneumonia. Mayo Clin Proc 1997;72:201-9.
3. Kaplan MN, Alling DW, Zimmermann HS, et al. A prospective trial of colchicine in primary biliary cirrhosis. N Engl J Med 1986;315:1448-54.
4. Kershenobich D, Varga F, Garcia Tao G, Perez-Tamayo R, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988;318:1709-13.
5. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation 1998;97:2183-5.
6. Seideman P, Fjellner B, Johannesson A. Psoriatic arthritis treated with oral colchicine. J Rheumatol 1987;14:777-9.
7. Hazen PG, Michel B. Management of necrotizing vasculitis with colchicine. Arch Dermatol 1979;115:1303-6.
8. Sullivan TP, King LE Jr, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol 1998;39:993-9.
9. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972;287:1302.
10. Escalante A, Ehresmann GR, Quismorio FP. Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine. Arthritis Rheum 1991;34:920-2.
11. Su WP, Fett DL, Gibson LE, Pittelkow SR. Sweet syndrome, acute febrile neutrophilic dermatosis. Semin Dermatol 1995;14:173-8.
12. Alarcon-Segovia D, Ramos-Niembro F, Ibanez-de Kasep G, Alcocer J, Tamayo RP. Long term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 1979;6:705-12.
13. Yazici H, Yurdakul S, Hamaryudan V. Behçet's disease: how should we treat it? Clin Immunother 1995;3:102-7.
14. Lange U, Schumann C, Schmidt KL. Current aspects of colchicine therapy: classical indications and new therapeutic uses. Eur J Med Res 2001;6:150-60.
15. Roberts WN, Liang MH, Stern SH. Colchicine in acute gout: reassessment of risks and benefits. JAMA 1987;257:1920-2.
16. Kontos HA. Myopathy associated with chronic colchicine toxicity. N Engl J Med 1962;266:38-9.
17. Riggs JE, Schochet SS Jr, Gutmann L, Crosby TW, DiBartolemeo AG. Chronic human colchicine neuropathy and myopathy. Arch Neurol 1986;43:521-3.
18. Neuss MN, McCallum RM, Brenckman WD, Silberman HR. Long-term colchicine administration leading to colchicine toxicity and death. Arthritis Rheum 1986;29:448-9.
19. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M. Colchicine myopathy and neuropathy. N Engl J Med 1987;316:1562-8.
20. Besana C, Comi G, Baldini V, Ciboddo G, Bianchi R. Colchicine myoneuropathy. Lancet 1987;2:1271-2.
21. Rieger EH, Halasz NA, Wahlstrom HE. Colchicine neuromyopathy after renal transplantation. Transplantation 1990;49:1196-8.
22. Grezard O, Lebranchu Y, Bimerle B, et al. Cyclosporin-induced muscular toxicity [letter]. Lancet 1990;335:177.
23. Younger DS, Mayer SA, Weimer LH, Alderson LM, Seplowitz AH, Lovelace RE. Colchicine-induced myopathy and neuropathy. Neurology 1991;41:943.
24. Wallace SL, Singer JZ, Duncan GJ, Wigley RM, Kuncl RW. Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol 1991;18:264-9.
25. Himmelmann F, Schroder JM. Colchicine myopathy in a case of familial Mediterranean fever: immunohistochemical and ultrastructural study of accumulated tubulin-immunoreactive material. Acta Neuropathol 1992;83:440-4.
26. Schiff D, Drislane FW. Rapid-onset colchicine myoneuropathy. Arthritis Rheum 1992;35:1535-6.
27. Caraco Y, Putterman C, Rahamimov R, Ben-Chetrit B. Acute colchicine intoxication: possible role of erythromycin administration. J Rheumatol 1992;19:494-6.
28. Jonsson J, Gelpi JR, Light JA, Aquino A, Maszaros S. Colchicine-induced myoneuropathy in a renal transplant patient. Transplantation 1992;53:1369-71.
29. Older SA, Finbloom DS, Pezeshkpour GH. Colchicine myoneuropathy and renal dysfunction. Ann Rheum Dis 1992;51:1342-5.
30. Cook M, Ramos E, Peterson J, Croker B. Colchicine neuromyopathy in a renal transplant patient with normal muscle enzyme levels. Clin Nephrol 1994;42:67-8.
31. Montseny JJ, Meyrier A, Gherardi RK. Colchicine toxicity in patients with chronic renal failure. Nephrol Dial Transplant 1996;11:2055-8.
32. Tapal MF. Colchicine myopathy. Scand J Rheumatol 1996;25:105-6.
33. Rutkove SB, De Girolami U, Preston DC, et al. Myotonia in colchicine myoneuropathy. Muscle Nerve 1996;19:870-5.
34. Lee BI, Shin SJ, Yoon SN, Choi YJ, Yung CW, Bang BK. Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient: a case report and review of the literature. J Korean Med Sci 1997;912:160-1.
35. Jagose JT, Bailey RR. Muscle weakness due to colchicine in a renal transplant recipient [letter]. N Z Med J 1997;110:343.
36. Rana SS, Giruliani MJ, Oddis CV, et al. Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients. Clin Neurol Neurosurg 1997;99: 266-70.
37. Ducloux D, Schuller V, Bresson-Vautrin C, Chalopin JM. Colchicine myopathy in renal transplant recipients on cyclosporin. Nephrol Dial Transplant 1997;12:2389-92.
38. Dawson TM, Starkebaum G. Colchicine induced rhabdomyolysis. J Rheumatol 1997;24:2045-6.
39. Duarte J, Cabezas C, Rodriguez F, Claveria LE, Palacin T. Colchicine-induced myopathy with myotonia. Muscle Nerve 1998;21:550-1.
40. Gruberg L, Har-Zahav Y, Agranat O, Freimark D. Acute myopathy induced by the colchicine in a cyclosporine treated heart transplant recipient: possible role of the multidrug resistance transporter. Transplant Proc 1999;31:2157-8.
41. Choi SS, Chan KF, Ng HK, Mak WP. Colchicine-induced myopathy and neuropathy. Hong Kong Med J 1999;5:204-7.
42. Shinde A, Nakano S, Abe M, Kohara N, Akiguchi I, Shibasaki H. Accumulation of microtubule-based motor protein in a patient with colchicine myopathy. Neurology 2000;55:1414-15.
43. Kaplan P, Kerr D, Conwit R. Weak and numb feet in a man with knobby hands. Arch Neurol 2000;57:271-3.
44. Akar S, Cavdar C, Birlik M, Onen F, Akkoc N. Myopathy in a patient with mild renal dysfunction and nasopharyngeal cancer; colchicine as a causative agent. Ann Med Sci 2001;10:85-6.
45. Chattopadhyay I, Shetty HG, Routledge PA, Jeffery J. Colchicine induced rhabdomyolysis. Postgrad Med J 2001;77:191-2.
46. Altiparmak MR, Pamuk ON, Pamuk GE, Hamuryudan V, Ataman R, Serdengecti K. Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol 2002;20(suppl 26):S13-16.
47. Fernandez C, Figarella-Branger D, Alla P, Harle JR, Pelissier JF. Colchicine-myopathy: a vacuolar myopathy with selective type 1 muscle fiber involvement: an immunohistochemical and electron microscopic study of two cases. Acta Neuropathol 2002;103:100-6.
48. Caglar K, Safali M, Yavuz I, Odabasi Z, Yenicesu M, Vural A. Colchicine-induced myopathy with normal creatine phosphokinase level in a renal transplant patient. Nephron 2002;92:922-4.
49. Hsu WC, Chen WH, Chang MT, Chiu HC. Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. Clin Neuropharmacol 2002;25:266-8.
50. Boomershine KH. Colchicine-induced rhabdomyolysis. Ann Pharmacother 2002;36:824-6.
51. Kissin EY, Corbo JC, Farraye FA, Merkel PA. Colchicine myopathy in a patient with familial Mediterranean fever and normal renal function. Arthritis Rheum 2003;49:614-16.
52. Caglar K, Odabasi Z, Safali M, Yenicesu M, Vural A. Colchicine-induced myopathy with myotonia in a patient with chronic renal failure. Clin Neurol Neurosurg 2003;105:274-6.
53. Soto O, Hedley-Whyte T. Case 33-2003: a 37-year-old man with a history of alcohol and drug abuse and sudden onset of leg weakness. N Engl J Med 2003;349:1656-63.
54. Minetti EE, Minetti L. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine. J Nephrol 2003;16:421-5.
55. Phanish MK, Krishnamurthy S, Bloodworth LL. Colchicine-induced rhabdomyolysis. Am J Med 2003;114:166-7.
56. Atmaca H, Sayarlioglu H, Kulah E, Demircan N, Akpolat T. Rhabdomyolysis associated with gemfibrozil-colchicine therapy. Ann Pharmacother 2002;36:1719-21.
57. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
58. Debie K, Conraads V, Vrints C. Colchicine-induced rhabdomyolysis in a patient with chronic heart failure. Acta Cardiol 2003;58:561-2.
59. Gendron Y, Bronstein JA, Gras C, Boz P. Neuromuscular toxicity of colchicine: a case. Nouv Presse Med 1989;18:1256.
60. Iwatsubo T, Ishige Y, Nukina N, Mannen T. Chronic human colchicine myopathy. Rinsho-Shinkeigaku 1990;30:1001-4.
61. Shibata K, Takeuchi M, Kikuchi M, Kobayashi I, Maruyama S. A case of Behcet's disease associated with myopathy during cyclosporine treatment. Rinsho-Shinkeigaku 1991;31:847.
62. Stefandis I, Bohm R, Hagel J, Maurin N. Toxic myopathy with kidney failure as a colchicine side effect in familial Mediterranean fever. Dtsch Med Wochenschr 1992;117:1237-40.
63. De Deyn PP, Ceuterick C, Saxena V, Crols R, Chappel R, Martin JJ. Chronic colchicine-induced myopathy and neuropathy. Acta Neuruologica Belgica 1995;95:29-32.
64. Sinsawaiwong S, Phanthumchinda K, Jongpiputvanich S. Colchicine-induced myopathy in renal failure. J Med Assoc Thail 1997;80:667-70.
65. Pascuzzi RM. Drugs and toxins associated with myopathies. Curr Opin Rheum 1998;10:511-20.
66. Repchinsky C, ed. Colchicine. In: Compendium of pharmaceutical specialties. Ottawa, Ontario, Canada: Canadian Pharmacists Association, 2004:459.
67. McEvoy GK, ed. Colchicine. In: AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists, 2003:3547-50.
68. Bennett WM, Aronoff GR, Berns JS, et al, eds. Miscellaneous agents. In: Drug prescribing in renal failure: dosing guidelines for adults, 4th ed. Philadelphia: American College of Physicians, 1999:77.
69. Cohen SL, Boner G, Shmueli D, Yusim A, Rosenfeld J, Shapira Z. Cyclosporin poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant 1989;4:201-4.
70. Rott KT, Agudelo CA. Gout: contemporary updates linking evidence and experience. JAMA 2003;289:2857-60.
71. Emmerson B. The management of gout. N Engl J Med 1996;334:445-51.
72. Terkeltaub RA. Gout. N Engl J Med 2003;349:1647-55.
73. Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993;27:337-43.